SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies
I think these headlines, possibly purposefully, overlook the possibility that vaccine antibodies eased acquisition of infection induced antibodies to the point of being subclinical events.<p>That is, a vaccinated person could be exposed to a variant for which they are partially protected, not notice clinical symptoms, while the person's immune system still remembers the details of the variant.<p>As an iterative process, this is akin to software updates (for a running immune system).<p>So to say that variant A.30 isn't covered by the mRNA induced spike protein antibodies is a very different statement than to say it's able to evade an immune system primed by mRNA antibodies which then re-entered daily life and thereby was able to continuously adapt to variants.